Neha Patil

Etalocib

Updated on
Share on FacebookTweet on TwitterShare on LinkedIn
Formula  C33H33FO6
Etalocib

How to pronounce etalocib


Etalocib is a drug candidate that was under development for the treatment of various types of cancer. It acts as a leukotriene B4 receptor antagonist and a PPARĪ³ agonist.

Clinical trials were conducted measuring efficacy for treatment of non-small cell lung cancer and pancreatic cancer and the inflammatory conditions asthma, psoriasis, and ulcerative colitis, but were suspended due to lack of efficacy.

References

Etalocib Wikipedia


Similar Topics
Flight Command
Adrian Amstutz
Paavo Paajanen
Topics